Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
5.79 (- 0.30)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

Conatus Update

Sep 2, 2014
View Presentation

View all »   RSSRecent Releases

Jan 8, 2015
Conatus Announces Top-Line Results From ACLF and Organ Impairment Clinical Trials of Emricasan

Jan 5, 2015
Conatus to Report Top-line Results From ACLF and Organ Impairment Clinical Trials of Emricasan

View all »Events & Presentations

Jan 8, 2015
Organ-impairment Clinical Trials Top-line Results
Webcast Listen to webcast
PDF View Presentation   2.7 MB   Add to Briefcase

Dec 10, 2014
Oppenheimer & Co. 25th Annual Healthcare Conference